Founders
Why we invested in Revisable
At NextUnicorn.Fund, our investment thesis centers on category-defining AI platforms tackling massive, high-friction knowledge domains—and medical test preparation is prime for disruption. Revisable has built India's premier AI-native medical learning ecosystem, anchored by "Ruby," an intelligent tutor trained on over a million pages of verified medical literature, clinical guidelines, and high-yield curricula. Rather than generic flashcards, Revisable combines algorithmic spaced repetition, dynamic Q-banks, and adaptive test analysis to pinpoint individual retention gaps and automate personalized revision schedules. With proven product-market fit—already trusted by over 100,000 medical aspirants across rigorous exams like NEET PG, INI-CET, FMGE, and USMLE—Revisable delivers exceptional learning efficiency and tangible rank outcomes at an accessible price point, positioning itself as an indispensable daily copilot for future clinicians.
Where Revisable is Headed
Revisable is not just streamlining exam revision; it is laying the foundation for a global, verticalized medical intelligence ecosystem. By expanding beyond India's high-stakes test-prep market into international licensing exams (such as USMLE, PLAB, and AMC) and ongoing clinical decision support for practicing healthcare professionals, Revisable commands a compounding data flywheel and high customer lifetime value. As generative AI becomes integral to continuous medical education and lifelong physician upskilling worldwide, Revisable possesses the vertical proprietary data, engagement moats, and cross-border scalability to capture a multi-billion-dollar global healthtech market—firmly charting its path toward becoming the next EdTech unicorn.
